Please provide your email address to receive an email when new articles are posted on . The approval is based on positive 1-year data from the phase 3 Pavilion study. This is Susvimo’s third ...

Specialists can identify subtle changes in the retina before symptoms appear and apply treatments that can slow or stop vision loss. Ophthalmologists specialize in the diagnosis and treatment of ...

For prevention of diabetic retinopathy (DR) incidence or progression, the American Academy of Ophthalmology Preferred Practice Pattern (AAO PPP) and the American Diabetes Association Standards of Care ...

Add Yahoo as a preferred source to see more of our stories on Google. Thanks to advancements in early detection and treatment options, it’s possible to live a long and healthy life after being ...

Credit: Genentech. Susvimo is indicated for intravitreal use via the Susvimo ocular implant. For patients with diabetic retinopathy, refills of Susvimo are administered every 36 weeks (approximately 9 ...

Sticking to your medication plan, managing your blood sugar, and taking care of your mental health can all be important components of self-care for diabetic retinopathy. Self‑care can’t cure diabetic ...

The Food and Drug Administration approved Genentech’s drug Lucentis to treat all forms of diabetic retinopathy — a complication of diabetes that leads to vision loss. Lucentis represents the first FDA ...

The five human senses include sight, hearing, smell, taste, and touch. While each of these matter for different reasons, they aren't perceived as being equal. For instance, according to a YouGov ...

Fundus photography involves taking a photo of the back of the eye to detect signs of diabetic retinopathy. It is also possible to capture an image of the retina using a smartphone. Diabetic ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being diagnosed with type 1 or type 2 diabetes. But since the chronic condition can ...